Ovarian Cancer
<ѻýҕl class="page-description">ѻýҕl>More in Ovarian Cancer
Risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas
Jul 18, 2024
Clear cell histology "is what yields the super response we see in these trials," expert suggests
Jun 04, 2024
Incidence, mortality double over 20 years, while estrogen plus MPA lowers endometrial cancer risk
May 24, 2024
The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study
Apr 09, 2024
Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all
Apr 08, 2024
About half of patients responded, duration of response as long as 19 months in three trials
Apr 05, 2024
Subspecialists could see only one patient a week with a new cancer diagnosis, researcher says
Mar 18, 2024
1.00
CME Credits
1.00
CME Credits